I am right there with you historian. Could you only imagine what the price of this stock will be by then?????
From the minutes of the PRAC (Pharmacovigilance Risk Assessment Committee) meeting in February, just published on EMEA website today : 3/8/16
14.1. Medicines in the pre-authorisation phase
As per agreed criteria, the PRAC endorsed without further plenary discussion the conclusions of the Rapporteur on the assessment of the RMP for the below mentioned medicines under evaluation for initial marketing authorisation application. Information on the medicines containing the below listed active substance(s) will be made available following the CHMP opinion on their marketing authorisation(s).
14.1.2. Amikacin - EMEA/H/C/003936, Orphan
Applicant: Insmed Limited
Scope: Treatment of nontuberculous mycobacterial lung infection
I have never written this but personally, I believe IPLEX is still being given to those original 13 FDA approved surviving ALS patients. I also believe the FDA has continued to monitor their progress. Yes, Insmed ran out of supply. This does not mean that the drug IPLEX has not been made available.
For instance, why [thankfully] is Debbie Gattoni of Wyckoff NJ alive? She once called IPLEX a miracle drug and cried with her husband when she was approved to obtain it back in 2008. Why is Josh Thompson [thankfully] of Virginia Beach stil alive? And why do residents continue that annual walk for him in his honor. In an article dated 05/16/15 it says 'Currently, IPLEX seems to be helping Josh function better on a day to day basis. He and Joy welcomed a second child into their family. Josh's future is looking better each day." [Goldwater-right to try] [that's 05/16/15] I thought the supply was exhausted? Hmmm
And just because an IPLEX MMD trial did not achieve its endpoint, does not mean it was unsuccessful. IPLEX will be available to market free of ANY royalty in 2018 and I'm sure the FDA will have something to say about it.
Sentiment: Strong Buy
$12.10 will be the lowest beginning monthly stock price for many many months to come as this stock ascends to higher and higher prices progressively forward. A great future awaits.
Arikayce, IPLEX, INS1009, Bp3, Inhaled Lipid Cisplaton, MRSA, IPF and Sarcoidosis
Now adding severe refractory asthma. Thanks INSMED
Sentiment: Strong Buy